间充质干细胞分泌的乳脂球表皮生长因子8可预防小鼠肝纤维化
研究鉴定脐带间充质干细胞分泌组中的抗纤维化蛋白,发现乳脂球表皮生长因子8(MFGE8)通过结合肝星状细胞αvβ3整合素下调TGFβI型受体,抑制TGFβ信号、减少细胞外基质沉积,小鼠中重组人MFGE8抗纤维化效果与分泌组相当,且肝硬化患者肝组织MFGE8水平低于对照。
要点
- 脐带间充质干细胞分泌组及其中MFGE8可减少小鼠肝纤维化细胞外基质沉积与肝星状细胞活化。
- MFGE8通过结合肝星状细胞αvβ3整合素下调TGFβI型受体,抑制TGFβ信号。
- 16例肝硬化患者肝组织MFGE8水平低于16例无肝硬化对照。
核心结论
- MFGE8是间充质干细胞分泌组中的抗纤维化蛋白,可强烈抑制TGFβ信号并减少小鼠细胞外基质沉积和肝纤维化。
研究设计与样本
- 研究将脐带间充质干细胞分化为肝细胞样细胞并收集培养基,用纳米芯片液相色谱-四极杆飞行时间质谱鉴定和定量分泌组蛋白。
- 小鼠通过腹腔注射硫代乙酰胺或四氯化碳诱导肝纤维化,部分小鼠随后注射分泌组或蛋白。
- 体外分析分泌组和候选抗纤维化蛋白对TGFβ1介导的人肝星状细胞系(hTert-HSC和LX2)及人原代肝星状细胞活化的影响。
- 收集韩国16例肝硬化患者和16例无肝硬化对照的肝组织进行免疫组化和免疫印迹分析。
主要发现
- 纤维化小鼠注射脐带间充质干细胞分泌组3天后细胞外基质蛋白积累显著减少,肝细胞样脐带间充质干细胞分泌组减少程度更大,表达α-SMA的活化肝星状细胞数量也减少。
- 脐带间充质干细胞分泌组及更大程度的肝细胞样脐带间充质干细胞分泌组降低肝脏多种纤维化因子、胶原、金属蛋白酶、TGFβ及TGFβ信号通路Smad蛋白表达。
- 在肝星状细胞系和原代肝星状细胞中,脐带间充质干细胞分泌组及更大程度的肝细胞样脐带间充质干细胞分泌组显著抑制TGFβ1刺激的α-SMA上调并降低SMAD2磷酸化。
- 鉴定出32种在肝细胞样脐带间充质干细胞分泌组中浓度更高且抑制TGFβ介导肝星状细胞活化的脐带间充质干细胞分泌组蛋白,其中MFGE8是人原代肝星状细胞活化的强抑制剂。
- MFGE8通过结合肝星状细胞αvβ3整合素下调TGFβI型受体表达,并由脐带、牙齿和骨髓来源间充质干细胞分泌。
关键数值与推荐
- 小鼠纤维化后3天,脐带间充质干细胞分泌组显著减少细胞外基质蛋白积累,肝细胞样脐带间充质干细胞分泌组减少程度更大。
- 鉴定出32种在肝细胞样脐带间充质干细胞分泌组中浓度更高且抑制TGFβ介导肝星状细胞活化的蛋白。
- 韩国16例肝硬化患者肝组织MFGE8水平低于16例无肝硬化对照。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Mesenchymal stem cells (MSCs) mediate tissue repair and might be used to prevent or reduce liver fibrosis. However, little is known about the anti-fibrotic factors secreted from MSCs or their mechanisms. METHODS: Umbilical cord-derived MSCs (UCMSCs) were differentiated into hepatocyte-like cells (hpUCMSCs), medium was collected, and secretome proteins were identified and quantified using nanochip-liquid chromatography/quadrupole time-of-flight mass spectrometry. Liver fibrosis was induced in mice by intraperitoneal injection of thioacetamide or CCl4; some mice were then given injections of secretomes or proteins. Liver tissues were collected and analyzed by histology or polymerase chain reaction array to analyze changes in gene expression patterns. We analyzed the effects of MSC secretomes and potential anti-fibrotic proteins on transforming growth factor β 1 (TGFβ1)-mediated activation of human hepatic stellate cell (HSC) lines (hTert-HSC and LX2) and human primary HSCs. Liver tissues were collected from 16 patients with liver cirrhosis and 16 individuals without cirrhosis (controls) in Korea and analyzed by immunohistochemistry and immunoblots. RESULTS: In mice with fibrosis, accumulation of extracellular matrix proteins was significantly reduced 3 days after injecting secretomes from UCMSCs, and to a greater extent from hpUCMSCs; numbers of activated HSCs that expressed the myogenic marker α-smooth muscle actin (α-SMA, encoded by ACTA2 [actin, alpha 2, smooth muscle]) were also reduced. Secretomes from UCMSCs, and to a greater extent from hpUCMSCs, reduced liver expression of multiple fibrotic factors, collagens, metalloproteinases, TGFβ, and Smad proteins in the TGFβ signaling pathways. In HSC cell lines and primary HSCs, TGFβ1-stimulated upregulation of α-SMA was significantly inhibited (and SMAD2 phosphorylation reduced) by secretomes from UCMSCs, and to a greater extent from hpUCMSCs. We identified 32 proteins in secretomes of UCMSCs that were more highly concentrated in secretomes from hpUCMSCs and inhibited TGFβ-mediated activation of HSCs. One of these, milk fat globule-EGF factor 8 (MFGE8), was a strong inhibitor of activation of human primary HSCs. We found MFGE8 to down-regulate expression of TGFβ type I receptor by binding to αvβ3 integrin on HSCs and to be secreted by MSCs from umbilical cord, teeth, and bone marrow. In mice, injection of recombinant human MFGE8 had anti-fibrotic effects comparable to those of the hpUCMSC secretome, reducing extracellular matrix deposition and HSC activation. Co-injection of an antibody against MFGE8 reduced the anti-fibrotic effects of the hpUCMSC secretome in mice. Levels of MFGE8 were reduced in cirrhotic liver tissue from patients compared with controls. CONCLUSIONS: MFGE8 is an anti-fibrotic protein in MSC secretomes that strongly inhibits TGFβ signaling and reduces extracellular matrix deposition and liver fibrosis in mice.
引用
- An SY, Jang YJ, Lim HJ, et al. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice. Gastroenterology. 2016. PMID: 27956229. doi:10.1053/j.gastro.2016.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。